Company & Sponsor Intelligence
West Virginia University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting2
Completed3
Countries1
Therapeutic footprint
adhdother_psychiatrypain_neuropathysubstance_use
Indexed studies
NCT05976672Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs
substance_use · United StatesNA
substance_use · United StatesNA
NCT06808503NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
other_psychiatry · United StatesNA
other_psychiatry · United StatesNA
NCT05260918Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT05963555PBM or Dry Float Therapy on Sleep Quality in Middle-aged and Elderly
other_psychiatry · United StatesNA
other_psychiatry · United StatesNA
NCT05353244Effects of PrTMS on Performance
other_psychiatry · United StatesNA
other_psychiatry · United StatesNA
NCT02543359A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)
adhd · United StatesNA
adhd · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →